Skip to main content

Table 2 Distribution of PSA level within each ISUP grade group (n = 189)

From: Risk of metastatic disease using [18F]PSMA-1007 PET/CT for primary prostate cancer staging

 

PSA (ng/mL)

 ≤ 10

10–20

 > 20

ISUP grade (n = 189)

   

1

3 (38%)

2 (25%)

3 (38%)

2

23 (56%)

12 (29%)

6 (15%)

3

26 (52%)

8 (16%)

16 (32%)

4

19 (56%)

9 (26%)

6 (18%)

5

29 (52%)

18 (32%)

9 (16%)

Unknowna

1 (20%)

1 (20%)

3 (60%)

  1. n(%) = number of patients (% of patients in ISUP grade group)
  2. aFive patients had missing ISUP grade information